University of North Dakota

UND Scholarly Commons
Nursing Capstones

Department of Nursing

6-15-2017

Continuous ST segment monitoring in the
operating room
Brett Cadwell

Follow this and additional works at: https://commons.und.edu/nurs-capstones
Recommended Citation
Cadwell, Brett, "Continuous ST segment monitoring in the operating room" (2017). Nursing Capstones. 167.
https://commons.und.edu/nurs-capstones/167

This Independent Study is brought to you for free and open access by the Department of Nursing at UND Scholarly Commons. It has been accepted for
inclusion in Nursing Capstones by an authorized administrator of UND Scholarly Commons. For more information, please contact
zeineb.yousif@library.und.edu.

Running head: ST SEGMENT MONITORING IN THE OR

CONTINUOUS ST SEGMENT MONITORING IN THE OPERATING ROOM
By
Brett Cadwell
Bachelor of Science in Nursing, North Dakota State University, 2002

An Independent Study
Submitted to the Graduate Faculty
of the
University of North Dakota
In partial fulfillment of the requirements
for the degree of
Master of Science
Grand Forks, North Dakota
December 2017

ST SEGMENT MONITORING IN THE OR

2

PERMISSION

Title: Continuous ST segment monitoring in the operating room
Department: Nursing
Degree: Master of Science

In presenting this independent study in partial fulfillment of the requirements for a graduate
degree from the University of North Dakota, I agree that the College of Nursing and Professional
Disciplines of this University shall make it freely available for inspection. I further agree that
permission for extensive copying or electronic access for scholarly purposes may be granted by
the professor who supervised my independent study work or, in her absence, by the chairperson
of the department or the dean of the School of Graduate Studies. It is understood that any
copying or publication or other use of this independent study or part thereof for financial gain
shall not be allowed without my written permission. It is also understood that due recognition
shall be given to me and to the University of North Dakota in any scholarly use which may be
made of any material in my independent study.

Signature_________________________

Date_________________________

ST SEGMENT MONITORING IN THE OR

3
Abstract

As anesthesia providers, the early detection and treatment of myocardial ischemia is
crucial in reducing the patients postoperative mortality related to cardiac complications. Heart
disease continues to be the leading cause of death in the United States. Delivering anesthesia to
patients in the operating room with increased risk factors for cardiovascular disease requires
increased vigilance, an advanced knowledge of the disease process and the monitoring tools
available to the anesthetist for the earliest detection of myocardial ischemia. The ECG monitor
has been used for decades in the operating room to monitor the heart rate of patients, but by
assessing the ST segment of the ECG we can more specifically monitor the heart for ischemia.
The purpose of this Independent Project is to provide a thorough and comprehensive review of
the latest literature related to the use of continuous ST segment monitoring in the operating
room. An expansive literature review was completed through the University of North Dakota’s
Harley E. French Library of Health Sciences. The literature provided current information on how
ECG patch placement and lead selection can impact the accuracy and sensitivity of early ST
segment changes. It also provided valuable information about the relationship between
tachycardia and ST segment changes and how the duration of ST segment changes can impact
the postoperative complication of myocardial infarction. The ability of the anesthetist to
accurately utilize the features of continuous ST segment monitoring can be an invaluable tool in
the prevention of postoperative complications.
Keywords: ECG, ST segment monitoring, myocardial ischemia, heart disease, anesthetic
management
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Continuous ST segment monitoring in the Operating Room
Background
Coronary artery disease remains the leading cause of death among both men and women
in the United States (Porth & Matfin, 2009). Patients who carry multiple risk factors for
coronary artery disease (CAD) can suffer from myocardial ischemia anytime when coronary
oxygen demand exceeds supply. Risk factors for CAD include: race, male gender, age greater
than 65y/o, hyperlipidemia, hypertension, cigarette smoking, diabetes mellitus, obesity and
family history of premature development of CAD (Hines & Marschall, 2008). Traditionally
practitioners have relied on patients to express symptoms of myocardial ischemia, such as chest
pain, as the first warning sign. Identifying perioperative myocardial ischemia can be difficult
because the anesthetized or sedated patient may not be able to express symptoms. Cardiac
complications are the most common cause of post-operative morbidity and mortality, with the
30-day mortality rate exceeding 2% in moderate to high risk non-cardiac surgery (Landesberg et
al., 2009).
There are multiple monitoring devices that can be used in the operating room to detect
myocardial ischemia including transesophageal echocardiography, pulmonary capillary wedge
pressures and electrocardiography (ECG). ECG is the most inexpensive, noninvasive and
technically simple to operate. ECG has been routinely used in the operating room for decades,
and is a standard of care for monitoring all patients receiving anesthesia (Nagelhout & Plaus,
2014). The ECG displays a continual tracing of the electrical activity of the heart from patches
strategically placed on the chest. The ST segment of the ECG can be diagnostic for myocardial
ischemia or infarction if there is elevation or depression from the patient’s baseline (Shanewise,
2006). Visual detection of ST segment changes has not been shown to be reliable, and thus one
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of the advancements in ECG monitoring is the ability of the monitor software to set a baseline
when the patient is initially connected and automatically, in real time, track the ST segment for
changes (Shanewise, 2006). Alarms can be set to notify the anesthetist if changes exceed a
predetermined elevation or depression. Proper use of this technology can be a very important
monitoring strategy for early detection of intraoperative myocardial ischemia for patients that
have increased risk factors for CAD or are undergoing a high risk surgery (Shanewise, 2006).
Case Report
The case being reviewed involved a 69 year old female with a history of renal cell
carcinoma presenting for a right open, radical nephrectomy for a urinary fistula after partial
nephrectomy. The patient’s height was 4’10 and weight was 76kg. She was categorized as an
ASA 3 and had allergies to Keflex, Morphine, Bactrim and Sulfa. Past medical history included
asthma, hypertension, dyslipidemia, diabetes type 2, atrial fibrillation with prior partial
nephrectomy, and chronic pain. Surgical history included a cholecystectomy, lumpectomy,
lithotripsy, cystoscopy, shoulder/knee and hip surgery. The patient reported no personal or
family history of anesthetic complications. Current medication regimen included Norvasc, baby
Aspirin, Lisinopril, Amoxicillin, Xanax, Flexeril, Levothyroxine, Glucophage, and Zocor. A
thorough preoperative examination included vital signs which were as follows: blood pressure
134/73, heart rate 90, respiratory rate 16, oxygen saturation 95% and a temperature of 97.9.
Laboratory data included a complete blood cell count noting a hemoglobin of 11.5 g/dl,
hematocrit 35.4 g/dl, and platelet count of 419 per mm^3. A complete metabolic panel was
within normal limits and an elevated hemoglobin A1C of 6.1. No coagulation studies were
completed. A pre-operative ECG was completed and demonstrated normal sinus rhythm with no
ST segment abnormalities and an echocardiogram showed an ejection fraction of 65%, mild
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(grade 1) diastolic failure, mild LV hypertrophy, no wall motion abnormalities or valvular issues
were noted. She was referred pre-operatively for a cardiology consultation and clearance for
surgery. Her consultation note addressed the fact that the patient’s METs was less than 4 with
fatigue being her predominant symptom and she was classified as an intermediate cardiovascular
risk due to her multiple risk factors and the proposed surgery. No further pre-operative studies
were recommended. The patient was not able to be started on a beta blocker because of prior
bradycardia. She was cleared for surgery.
When the patient entered the operating room, the standard monitors were placed
including a 5-lead ECG. The patches were placed in the normal position on the chest, with the V
lead (brown) placed in the V5 position (5th intercostal space, half way between the midclavicular
line and the mid axillary line). Continuous ST segment monitoring was initiated, a baseline J
point was established for the 7 leads displayed and an ECG strip was printed prior to induction.
Her airway assessment included a Mallampati I, normal thyromental distance, normal
inter-incisor distance and full range of motion of her neck. After pre-oxygenation, induction
medications were given as follows: fentanyl 100mcg, propofol 150mg and rocuronium 50mg.
The patient was intubated with a 7.0 ETT using a MAC 3 blade. Correct placement was
confirmed with bilateral breath sounds and presence of an end tidal carbon dioxide wave form.
The endotracheal tube was taped and secured while the patient was placed on volume control
ventilation with a tidal volume of 550ml, rate of 12, positive end expiratory pressure of 5cm
H2O with an inspiratory pressure ranging around 20cm H2O. Sevoflurane 2% was used as the
inhalational anesthetic. An arterial line was started in the left radial artery with a good waveform
and an additional 18G IV was started in the forearm.
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Prior to incision the patient was given 1250mg of Vancomycin, 1 gram of Ofirmev and
100mcg of fentanyl. During the case the patient was given an additional 200mcg of fentanyl for
analgesia and re-dosed three times with 10mg rocuronium to maintain 2/4 twitches. The case
lasted three hours and was complicated by an increased blood loss to total 1100ml. The patient
was given a total of 2500ml of lactated ringers and 500ml albumin. A hemoglobin was rechecked
after the first 500mls of blood loss and resulted at 8.8 g/dl. The patient was cross matched for 2
units of RBCs and were administered prior to the end of the case. The patient’s vital signs
remained relatively stable throughout the case, only requiring 300mcg of phenylephrine to keep
her BP within 20% of her normal. She remained sinus rhythm and her ST segments only
deviated 0.1-0.3mm from the baseline throughout the case.
At the end of the procedure, muscle relaxants were reversed with 0.6mg glycopyrolate
and 3mg neostigmine. Anti-emetics included Decadron 4mg and Zofran 4 mg. The patient was
extubated awake without complications and placed on 4L O2 per nasal cannula. In the recovery
room she denied any pain or nausea. The patient’s hemoglobin the next day was 10.5 g/dl, she
was discharged home 4 days later without complications.
Discussion

Coronary Heart Disease
Epidemiology
In 2010, the overall death rate attributed to cardiovascular disease had decreased by 31%
compared to 2000 but the overall burden of disease has remained high. (American Heart
Association). The total direct/indirect cost for care related to cardiovascular disease and stroke
was estimated at $315.4 billion, compared to 201.5 billion for cancer care. It is the most
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expensive of all diagnostic groups (AHA, 2014). According to the American College of
Cardiology and the American Heart Association (ACC/AHA) the prevalence of coronary artery
disease increases with age. The population over the age of 65, is the fastest growing age group,
and is estimated to grow 25-35% over the next 30 years (2007). “Thus, it is conceivable that the
number of non-cardiac surgical procedures performed in older persons will increase from the
current 6 million to nearly 12 million per year, and nearly one fourth of these—major intraabdominal, thoracic, vascular, and orthopedic procedures—have been associated with significant
perioperative cardiovascular morbidity and mortality” (ACC/AHA, 2007, p.162).

Risk Factors
There are numerous risk factors that contribute to the development of coronary artery
disease including: male gender, increasing age, hyperlipidemia, hypertension, cigarette smoking,
obesity, diabetes mellitus, sedentary lifestyle, family history and even psychological factors such
as stress and having a type A personality (Hines & Marschall, 2008). As part of its 2020 Impact
Goals, the American Heart Association is trending data on seven “health metrics” it believes are
reflective of cardiovascular health. These metrics are smoking, body mass index, physical
activity, healthy diet, total cholesterol, blood pressure and fasting plasma glucose (2014). Due to
the broad range of risk factors that can contribute to coronary artery disease, there have been
multiple risk calculators developed to try and assist the anesthetist in predicting pre-operative
risk.

The 2014 ACC/AHA perioperative guidelines highlight estimating this risk based on a
combination of both clinical risk factors and the surgical procedure being performed. For patients
with risk factors for stable coronary artery disease, the ACC/AHA recommended the use of the
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Revised Cardiac Risk Index (RCRI) or the National Surgical Quality Improvement Program
(NSQIP) risk calculator (ACC/AHA, 2014). The NSQIP was developed by the American
College of Surgeons and uses 20 patient predictors combined with the surgical procedure to
predict the odds of a patient having 15 different adverse outcomes in the 30 days following
surgery (UpToDate, 2016).

The RCRI is more specific to predicting cardiac complications including specifically
myocardial infarction. The RCRI predicts this risk based on six factors: high risk surgery
(intraperitoneal, intrathoracic, vascular or suprainguinal), history of ischemic heart disease,
history of congestive heart failure, history of cerebral vascular accident, pre-operative treatment
with insulin and pre-operative creatinine of >2mg/dl (UpToDate, 2016). Using the RCRI, the
patient in this case study, would have received only one point (for high risk surgery) which
translates to a 0.9% risk of a major cardiac event (UpToDate, 2016). According to the
perioperative cardiac assessment algorithm, because this patient’s risk was <1%, no further
testing was needed. If her risk had been >1%, the next step would have taken into consideration
her METs <4 (ACC/AHA, 2014). MET, or metabolic equivalent of the task, is an assessment of
functional capacity or O2 consumption with activity. The ability to perform activities requiring 4
METs or more (such as climbing a flight of stairs or walking at >4mph) indicates good
functional capacity. Perioperative cardiac risk can be increased with a METs <4 (Hines &
Marschall, 2008). Like the patient in this case study, MET level can also be influenced by an
underlying medical condition limiting their activity, so assessment of this can be inaccurate or
nonspecific (similar to a patient with orthopedic problems).
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Myocardial Ischemia
Myocardial ischemia can happen anytime that myocardial oxygen demand exceeds
coronary artery blood flow or oxygen supply (Morgan & Mikhail, 2013). This can be caused by
atherosclerosis of the coronary arteries, thrombosis, severe hypertension or hypotension,
tachycardia, hypoxemia, anemia or severe valvular disease (Morgan & Mikhail, 2013).
Atherosclerosis is the most common cause of ischemia and is now being recognized as an
inflammatory disease (Hines & Marschall, 2008). The multiple risk factors as stated above lead
to the development of atherosclerotic plaque, which is made up of inflammatory cells. These
plaques can be vulnerable to rupture due to their lipid core and thin fibrous caps (Hines &
Marschall, 2008). When they rupture a cascade of events including platelet aggregation,
activation and vasoconstriction can lead to complete coronary obstruction and thus myocardial
infarction (Hines & Marschall, 2008). In the operating room, myocardial ischemia could be due
to either an inflammatory response or a neuroendocrine stress response (Hines & Marschall,
2008). Surgery itself can create a pro-thrombotic environment, leading to decreased oxygen
delivery similar to the plaque rupture described above. Catecholamine release can lead to
tachycardia and hypertension that can both increase the propensity for plaque rupture but also
increase the oxygen demand in a patient with an already compromised myocardial supply (Hines
& Marschall, 2008).

Signs & Symptoms

The most common symptom of myocardial ischemia is angina. When the myocardium is
ischemic it releases adenosine and bradykinin which stimulates the receptors of the thoracic
sympathetic and somatic nerve fibers in the spinal cord that result in angina (Hines & Marschall,
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2008). Angina can also radiate to the left arm, shoulder, neck or jaw. Other symptoms can
include shortness of breath, epigastric pain, nausea or diaphoresis. In some patients, especially
with a history of diabetes, there can be no symptoms at all (Hines & Marschall, 2008). Having
the patient anesthetized in the operating room, complicates the early diagnosis of myocardial
ischemia because they are unable to verbalize their symptoms. Some secondary signs that may
be noticeable with perioperative monitoring include slow atrioventricular nodal conduction and
hypotension due to decreased contractility (Hines & Marschall, 2008). Unfortunately, these are
very non-specific signs, which can also be contributed to the anesthetics themselves. Tachycardia
has been found to precede myocardial ischemia in many cases, due to the increased oxygen
demand, and thus its presence can be a sign to the anesthetist to watch for ischemic changes on
the ECG (Landesberg, 1993; Landesberg, 2001).

Cardiac Monitoring

Transesophageal Echocardiography (TEE)
Echocardiography can be used to identify myocardial ischemia through the detection and
localization of regional wall motion abnormalities (RWMA) (Nagelhout & Plaus, 2014). When
a segment of the myocardium is experiencing a perfusion deficit, that segment has less
thickening and motion towards the center of the ventricle than normal, which is called
hypokinesis (Shanewise, 2006). This can happen within one minute of a perfusion deficit, thus
making it a more sensitive monitor than ST segment changes (Shanewise, 2006). RWMA can be
caused by other factors than ischemia, including conduction abnormalities, sudden changes in
preload or afterload and severe dysfunction of the right ventricle (Nagelhout & Plaus, 2014).
Although it is more sensitive than ECG, there are several limitations to its use. These include its
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cost effectiveness in non-cardiac operations, it requires the anesthetist to have specific training in
its use for proficiency, it is not practical for use in a continuous fashion like ECG, it can only
visualize a small portion of the ventricle in a single view thus possibly missing ischemia in a
non-visualized area and its use is limited to the period of time while intubated thus missing the
critical time for ischemia during induction and emergence (Shanewise, 2006)(ACC/AHA, 2007).
The 2014 ACC/AHA perioperative guidelines state, “the routine use of intraoperative
echocardiogram during non-cardiac surgery to screen for cardiac abnormalities or to monitor for
myocardial ischemia is not recommended in patients without risk factors or procedural risk for
significant hemodynamic, pulmonary or neurological compromise”.

Pulmonary Capillary Wedge Pressures (PCWP)
Pulmonary artery catheterization can be used to monitor for intra-operative myocardial
ischemia by measuring trends of the pulmonary artery wedge pressures (Nagelhout & Plaus,
2014). If the left ventricle function was to become impaired, there could be an increase in left
ventricular end diastolic pressures (LVEDP), as indirectly measured by the pulmonary artery
wedge pressure (Nagelhout & Plaus, 2014). Because LVEDP is only indirectly measured, other
factors can falsely influence its trend including: mitral stenosis, COPD, increased pulmonary
vascular resistance, and location of the catheter in the lung (Shanewise, 2006). Thus studies have
concluded that PCWP does not have good sensitivity or specificity for detecting myocardial
ischemia (Shanewise, 2006). It is also an invasive procedure that can have serious complications
and requires the anesthetist to have knowledge and experience in interpreting its results
(Nagelhout & Plaus, 2014). The 2014 ACC/AHA guidelines state that the use of pulmonary
artery catheters may aid in the hemodynamic management of an already critically ill patient
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undergoing surgery but that its routine use, even with patients with elevated risk, is not
recommended.
ST Segment
The ST segment of the ECG is measured from the J point (the point at which the QRS
segment ends and the ST segment begins) and ends at the beginning of the T wave (Nagelhout &
Plaus, 2014). This segment should be isoelectric (or flat) as it represents when ventricular cells
are in the plateau phase after depolarization and there is no electrical conduction (Nagelhout &
Plaus, 2014). Ischemic or damaged tissue causes the cells of the myocardium to react
abnormally. An ST segment that is depressed is indicative of myocardial ischemia due to either
increased oxygen demand or limited coronary blood flow (Hines & Marschall, 2008). If the ST
segment is elevated, there is total occlusion of a coronary artery, leading to a myocardial
infarction (Hine & Marschall, 2008). When calculating the ST segment for deviation, it is
compared to the preceding PR segment as an isoelectric reference (Nagelhout & Plaus, 2014).
There are differing opinions on where the ST segment should start being assessed. Some
literature/manufacturers measure the ST segment starting at the J point, and some start 60 or 80
milliseconds from the J point (Nagelhout & Plaus, 2014). This debate will not be reviewed in this
discussion. When the ECG is first connected to the patient, a baseline of the ST segment is
established per the manufacturer’s analysis algorithm or a baseline can be set manually by the
anesthetist (Drew et al., 2004). From this point on, subsequent ST segments will be compared to
this baseline and displayed on the monitor as a positive or negative numerical value. Alarm
parameters are generally set to notify the anesthetist if the ST segment were to change 1 to 2mm
above or below the baseline, as this is generally considered significant (Drew et al., 2004).
Clinical implications of this include: discharging the previous patient from the monitor prior to
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re-establishing an ECG so that the previous patient’s ST segment baseline is not used for
comparison, changing the position of an ECG electrode after baseline is established can produce
false alarms because of the change in deflection, and a change in body position can alter ST
segments, mimicking ischemia. If possible obtain the baseline ECG in the side-lying surgical
position prior to induction (AACN, 2016). Patients that have a previously documented left
bundle branch block or have a ventricular paced rhythm are generally not candidates for
continuous ST segment monitoring because the nature of their ST segment is already steeply
sloped which leads to frequent false alarms (Drew et al., 2004).
Lead Placement
In the operating room, either a 3-lead or a 5-lead ECG is used for monitoring. For this
discussion, we will focus on the 5-lead ECG, as there is increased sensitivity in the identification
of myocardial ischemia when multiple leads are monitored (Nagelhout & Plaus, 2014). A 5-lead
ECG, as the name indicates, involves five ECG electrodes. It allows the anesthetist to monitor
seven “views” of the heart. Even though the monitor only displays a continuous ECG waveform
for two leads, it is monitoring the ST segments of all seven “views” (Drew et al., 2004).
Limb lead placement and corresponding areas of surveillance
There are four limb electrodes-the white electrode is placed on the right side of the upper
chest under the clavicle, the green electrode can be placed in any convenient location on the right
side of the trunk, the black electrode is placed on the left side of the upper chest under the
clavicle and the red is placed on the lower left side of the flank in the anterior axillary line
(Nagelhout & Plaus, 2014). These four electrodes placed on the perimeter of the chest, allow for
the monitoring of six limb leads- I, II, III, AVL, AVR and AVF (Drew et al., 2004). Leads I and
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AVL monitor the lateral wall of the myocardium that corresponds with the circumflex
distribution of coronary blood flow. Leads II, III and AVF monitor the inferior wall that
corresponds with the right coronary artery. AVR is generally not used as a diagnostic lead
(AACN, 2016).
Precordial lead placement and corresponding area of surveillance
The fifth electrode is placed in one of the six precordial positions, and its position
determines the anatomical area of the heart being monitored (Drew et al., 2004). Correct
placement of these precordial leads is important because inaccurate placement can change the
deflection of the waveform and potentially delay the sensitivity of that lead in the detection of ST
segment changes (Drew et al., 2004). For the patient that has pre- or intra-operative ST segment
changes and is going to be monitored in the post-operative period for ischemia, marking the
location of the electrodes with indelible ink to ensure replacement of the patches to the same
location is imperative as relocating as little as 1 cm away from its original location can lead to
waveform changes (AACN, 2016).
Placement of the electrode for lead V1 is in the fourth intercostal space, right of the
sternal border. Lead V2 is placed in the fourth intercostal space, left of the sternal border. V1 and
V2 are monitoring the septal wall and the distribution of the left anterior descending coronary
artery. ST depression in V1-2 can also be a reciprocal change that reflects posterior infarction
related to the right coronary artery or the circumflex. Lead V3 is placed equal distance between
V2 and V4. Lead V4 is placed in the midclavicular line at the fifth intercostal space. Leads V3
and V4 monitor the anterior wall of the myocardium supplied by the left anterior descending
artery. The V5 electrode is placed horizontal to V4 on the anterior axillary line, half way
between V4 and V6. V6 is placed horizontal to V5 on the mid-axillary line. V5 and V6, along
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with leads I and AVL, monitor the lateral wall supplied by the circumflex artery (Nagelhout &
Plaus, 2014; AACN, 2016).
Lead Selection
The choice of what ECG leads to monitor the patient during the perioperative period is
based on their history and pre-operative 12-lead ECG. As previously discussed, the four limb
leads will always allow for continuous ST segment monitoring of leads I, II, III, AVF, AVR and
AVL (Drew et al., 2004). So the decision left to be made is, which precordial (or V lead) is going
to show the earliest ST segment changes specific to this patient and their history. Improper
selection of this V lead can lead to unrecognized myocardial ischemia or infarction (Nagelhout &
Plaus, 2014). If the patient has a pre-operative 12-lead that has ST segment changes in a specific
lead, known as the ST fingerprint, than that lead should be monitored throughout the case. An ST
fingerprint is a pattern of ST segment elevation or depression that is unique to a specific patient
(AACN, 2016). Also if the patient has known coronary artery disease in a specific vessel, or recent
coronary intervention, the leads selected should correspond with that coronary artery distribution
(AACN, 2016).
The debate and change in practice comes in with patients that do not have documented
coronary artery disease or a remarkable pre-operative 12-lead ECG. A systematic review of
studies completed in the 1980-1990s and published in the Best Practice and Research of Clinical
Anesthesiology, addressed the topic of monitoring for myocardial ischemia. This review was a
synthesis of eighteen studies that addressed multiple topics related to perioperative ischemia and
postoperative cardiac complications (Landesberg, 2005). One of the topics was continuous 12-lead
ECG monitoring and lead sensitivity. At the time, and interestingly still used commonly today,
lead II and V5 were primarily monitored in the OR and detected only 80% of significant ST
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changes (Landesberg, 2005). These studies were based on information gained from Holter
monitoring in the outpatient setting to detect demand ischemia and they used absolute versus
relative ST segment deviation (Landesberg, 2005). More recently, with the advancement of
automated ST segment monitoring algorithms, studies have been completed during the
intraoperative and postoperative periods using continuous 12-lead ECGs to determine the most
sensitive leads for ischemia. In a landmark 2002 study, 185 patients undergoing vascular surgery
were monitored in this fashion, with ischemia defined as ST segment deviation of 2mm in one lead
or 1mm in two contiguous leads from the patient’s preoperative baseline (Landesberg, Mosseri,
Wolf, Vesselov, & Weissman, 2002). Post-operative infarction was defined by an elevation in
troponin I levels. Of the 185 patients, 38 had transient ischemic events (ST depression) with 12 of
those patients sustaining postoperative myocardial infarctions (Landesberg et al., 2002). It was
found that lead V3 most frequently (86.6%) demonstrated ischemia and was the earliest to show
changes, followed by V4 (78.9%) and V5 (65.8%). For the patients that suffered myocardial
infarction, V4 was the most sensitive and the earliest in detecting ischemia (83.3%), followed by
V3 and V5 (75% each) (Landesberg et al., 2002). The overall sensitivity in the detection of
ischemia was 94.7% when either V3 or V4 was combined with the limb leads, compared to 76.3%
when V5 was combined with the limb leads (Landesberg et al., 2002).
In 2005, a council of experts in Cardiology, Electrophysiology and Critical Care Nursing
came to together to author the first formal standard for electrocardiographic monitoring in the
hospital setting (Drew & Funk, 2006). From these practice standards the ACC/AHA derived
guidelines for intraoperative ST segment monitoring in patient’s undergoing non-cardiac surgery
and recommend the use of V4 rather than V5 for the early detection of ischemia (2007). In 2008,
the American Association of Critical Care Nurses published a practice-alert on ST-segment
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monitoring for all patients in the Intensive Care Unit at risk for demand ischemia (this included
weaning from the ventilator). This practice-alert was based on a systematic review of literature on
ST segment monitoring (Fox, Kirkendall & Craney, 2010).
As related to lead selection, leads V3 and III were found to be the most sensitive in
detecting ischemia especially for patients with a cardiac history or numerous risk factors (Fox,
Kirkendall & Craney, 2010). However the author stressed the importance of monitoring in a
patient’s “fingerprint” lead if they have had a previously documented ST segment change, as it
will be the most sensitive lead in their case (Fox, Kirkendall & Craney, 2010). Of the limb leads,
lead III has been found to be the most sensitive in detecting ischemia (Drew & Tisdale, 1993)
(Flanders, 2007). As lead III is a limb lead that is continuously being monitored by the monitor’s
algorithm, this is not of as much importance as lead selection for chest leads. Lead II is more
useful to have continually displayed for arrhythmia detection, especially atrial. The anesthetist
needs to be aware of the numerical changes in lead III for ST segment deviation and have the
appropriate alarms set (Flanders, 2007).
There are monitoring systems that can do continuous ST segment monitoring of all 12leads from a five electrode ECG system. This is called a derived 12-lead or EASI. The five
electrodes are placed in a specific configuration on the chest and allow for a more comprehensive
assessment of the myocardium. Monitoring more than one V lead simultaneously, increases the
sensitivity of ischemia detection from roughly 85% to 96% (Shanewise, 2006) (Landesberg, 2002).
The use of this derived 12-lead also eliminates the need for the anesthetist to make a decision
regarding the most appropriate chest lead. This type of monitoring is not equivalent to a 12-lead
ECG but can closely correspond if used appropriately (AACN, 2016).
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Perioperative myocardial infarction and ECG monitoring
As discussed earlier, perioperative myocardial infarction (PMI) can occur from either
plaque rupture leading to acute coronary syndrome or from an imbalance in oxygen supply and
demand (Landesberg et al, 2009). Studies from the 1990s and 2000s found common similarities
among patients who suffered PMI. They found a strong association between long duration (>20
minutes) ST segment depression and progression to postoperative complications including
myocardial infarction and death (Landesberg, 1993; Landesberg, 2001; Landesberg, 2009). In
these studies, perioperative cardiac events were rarely (<2%) or never, preceded by ST segment
elevation (Landesberg, 1993; Landesberg, 2001). The longer the duration of ST segment
depression, the higher the postoperative trend of troponin levels (Landesberg, 2001). To note, these
studies were completed on high risk patients undergoing vascular surgery. Another similarity in
the studies was that each episode of ST segment depression was preceded by tachycardia from the
patient’s baseline (ranging from 90-120bpm). In the 2001 Landesberg study, patients were
monitored using 12-lead ECG prior to induction through 72 hours post-operatively. According to
this study, “twenty-six (68%) of all the longest ischemic events started during the period between
50 min before and 60 min after the end of surgery, during emergence from anesthesia (a time
characterized by an increase in heart rate, blood pressure, sympathetic discharge and pro-coagulant
activity). In eight (67%) of the patients with PMI, the longest ischemic episodes started within the
same time period” (Landesberg, 2001, p.1842, 1843). None of the patients had significant ischemia
(defined as less than 10minutes) during induction (Landesberg, 2001). Landesberg’s prior study
in 1993 highlighted a similar connection between ST depression and tachycardia, but this study
found that the majority of “long duration” ST depression occurred in the postoperative period but
shorter episodes were identified during high demand, low supply periods in the OR (intubation,
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emergence and extubation). Both studies noted that the ST depression was transient in all episodes,
highlighting the importance of continuous ST segment monitoring (Landesberg, 1993;
Landesberg, 2001).
Although further studies are needed to identify if early detection would reduce the mortality
associated with perioperative myocardial ischemia- a few highlights can be identified regarding
intraoperative monitoring. The importance of preventing and having a low threshold for treatment
of tachycardia is essential. As the episodes of ST depression were transient, choosing the most
sensitive leads for its detection, will allow the anesthetist to identify that patient’s specific
fingerprint leads that show ischemia during periods of high demand and low supply. This early
detection may allow the anesthetist to more aggressively reverse the cause of ischemia, limiting
the time of ST depression and hopefully decreasing the incidence of post-operative myocardial
complications. Identification of which leads the patient typically has been showing ST segment
depression could also translate into consistency across the phases of care into the post-operative
period in the early detection of myocardial ischemia.
Case Study Review
In retrospect, the case study discussed previously was a good example of a typical patient
with increased risk factors for heart disease (age, hypertension, type 2 diabetes and
hyperlipidemia) but based on cardiac preoperative evaluation was only deemed low to
intermediate risk. Her preoperative ECG was noncontributory but her METs less than 4 due to
fatigue was concerning. The ability to do continuous ST segment monitoring in the operating
room was a valuable, simple and cost effective tool for this patient. Assuring that the ECG
patches were placed in the appropriate positions for the most accurate data, establishing a
baseline for the J point, identifying that the ST segment alarms were on and set to alarm with
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1mm of elevation or depression were important steps in correctly monitoring for ST segment
changes. Printing an ECG strip prior to induction is also a good practice for reference of the
baseline throughout the case. The accuracy of these steps was confirmed by the literature
reviewed in this Independent Project.
A highlighted area for improvement though was the selection of V5 for the chest lead.
The evidence suggests that monitoring the patient in V5 is based on outdated literature and is not
the most sensitive chest lead in the detection of ST segment changes. Since this patient did not
have documented coronary artery disease, V4 would have been the more appropriate and
sensitive chest lead for monitoring. Of the limb leads, lead III would show the earliest ST
segment changes. It is still appropriate to display lead II, as the monitor will alarm automatically
if there is deviation of 1mm in lead III without it being continuously displayed. The literature
also highlighted the importance of accurate placement of ECG patches, especially the brown
patch, as its placement is what directly dictates the chest lead being monitored, and thus the
sensitivity to early ST segment changes. The patient did face a potential imbalance in her
oxygen supply versus demand due to the increased blood loss but with timely replacement of her
volume status with a combination of crystalloid, colloid and red blood cells her vital signs
remained stable without any significant change in her ST segments from baseline. She also did
not experience any episodes of tachycardia throughout the case, which the literature found to
precede most incidence of ST segment depression. Again, the use of continuous ST segment
monitoring was an appropriate and valuable tool in the assessment of intraoperative myocardial
ischemia.
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Conclusion
Although the incidence of intraoperative myocardial infarction is low, the mortality and
costs associated with the adverse outcomes are high. As a large portion of our population ages,
patients have more risk factors for heart disease and surgical options for treatment become more
common, there is reason for the anesthetist to remain vigilant in the early recognition and
possible reversal of myocardial ischemia during surgery. Changes in the ST segment of the ECG
correlate with myocardial ischemia or infarction. Continuous ST segment monitoring on the
ECG is a simple, cost effective and generally available tool for early recognition. Like most
monitoring devices, it is essential that the anesthetist be knowledgeable in its use to provide the
most accurate data. Evidence highlights the importance of accurate ECG patch placement, lead
selection, establishment of baseline and setting appropriate audible alarms to ensure the earliest
recognition of ST segment changes. Our anesthetic plan and early treatment during periods of
imbalance in myocardial oxygen demand and supply was crucial in the avoidance of ischemia.
The evidence provided in this Independent Project will educate anesthesia providers in the
accurate use of continuous ST segment monitoring, thus providing their patients with the safest
intraoperative experience.
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